Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

158 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Phase II study of pemetrexed disodium, a multitargeted antifolate, and cisplatin as first-line therapy in patients with advanced nonsmall cell lung carcinoma: a study of the National Cancer Institute of Canada Clinical Trials Group.
Shepherd FA, Dancey J, Arnold A, Neville A, Rusthoven J, Johnson RD, Fisher B, Eisenhauer E. Shepherd FA, et al. Cancer. 2001 Aug 1;92(3):595-600. doi: 10.1002/1097-0142(20010801)92:3<595::aid-cncr1359>3.0.co;2-d. Cancer. 2001. PMID: 11505404 Clinical Trial.
New targets for cancer chemotherapy.
Arbuck SG, Dancey J, Pluda JM, Grochow L, Murgo AJ, Ivy P, Wright J, Blaylock B, Via LE, Sausville EA. Arbuck SG, et al. Cancer Chemother Biol Response Modif. 2001;19:237-88. Cancer Chemother Biol Response Modif. 2001. PMID: 11686017 Review. No abstract available.
Agents targeting ras signaling pathway.
Dancey JE. Dancey JE. Curr Pharm Des. 2002;8(25):2259-67. doi: 10.2174/1381612023393071. Curr Pharm Des. 2002. PMID: 12369854 Review.
158 results